Stephan Rosshart

Current position

W3 Professor, Head of the Department of Microbiome Research, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

Academic training

2003 - 2009	Study of Medicine in Freiburg with electives in the USA (Memorial Sloan-Kettering Cancer Center New York) and Switzerland (Kantons Hospital Frauenfeld)
2001 - 2003	Study of Biology in Freiburg

Scientific training

2009	Dissertation in Medicine, University of Freiburg (Supervisor: Prof. Dr. Hanspeter Pircher)

Postgraduate positions

since 2023	W3 Professor, Head of the Department of Microbiome Research, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
since 2021	Emmy Noether group leader and head of the gnotobiotic mouse facility, Department of Medicine II, Medical Center – University of Freiburg
2019 - 2021	Group leader and head of the gnotobiotic mouse facility, clinical fellow, Department of Medicine II, Medical Center – University of Freiburg
2013 - 2019	Postdoctorate (NIH fellowship), Immunology Section, Liver Diseases Branch, NIDDK, NIH, Bethesda, MD, USA
2009 - 2013	Clinical fellow, Department of Medicine II, Medical Center – University of Freiburg

Miscellaneous (Honors, Awards)

2021	DFG Emmy Noether-Program
2020	DFG IMM-PACT Clinician Scientist-Programm, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
2017	Fellows Award for Research Excellence (FARE), National Institutes of Health (NIH), Bethesda, MD, USA
2013 & 2015	NIDDK Visiting Fellowship Award, National Institutes of Health (NIH), Bethesda, MD, USA
2010	Young Investigator Award for Experimental and Clinical Cancer Research by Pfizer Company, Freiburg, Germany
2000	Award for an outstanding High School Diploma by the EnergieDienst GmbH, Weil am Rhein, Germany

link to all publications from S. Rosshart: Pubmed

Publications based on CRC1160 funding

Torcellan T, Friedrich C, Doucet-Ladevèze R, Ossner T, Solé VV, Riedmann S, Ugur M, Imdahl F, Rosshart SP, Arnold SJ, Gomez de Agüero M, Gagliani N, Flavell RA, Backes S, Kastenmüller W, Gasteiger G. 2024. Circulating NK cells establish tissue residency upon acute infection of skin and mediate accelerated effector responses to secondary infection. Immunity. 2024 Jan 9;57(1):124-140.e7. doi: 10.1016/j.immuni.2023.11.018.

Ma J, Urgard E, Runge S, Classon CH, Mathä L, Stark JM, Cheng L, Álvarez JA, von Zedtwitz S, Baleviciute A, Martinez Hoyer S, Li M, Gernand AM, Osbelt L, Bielecka AA, Lesker TR, Huang HJ, Vrtala S, Boon L, Beyaert R, Adner M, Martinez Gonzalez I, Strowig T, Du J, Nylén S, Rosshart SP, Coquet JM. 2023. Laboratory mice with a wild microbiota generate strong allergic immune responses. Sci Immunol. 8(87):eadf7702. doi: 10.1126/sciimmunol.adf7702.

Zeiser R, Warnatz K, Rosshart S, Sagar, Tanriver Y. 2022. GVHD, IBD and primary immunodeficiencies: The gut as a target of immunopathology resulting from impaired immunity. Eur J Immunol. 52(9):1406-1418. doi: 10.1002/eji.202149530.